Allogene Therapeutics
ALLO
ALLO
94 hedge funds and large institutions have $1.85B invested in Allogene Therapeutics in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 86 → 94 (+8)
2.85% more ownership
Funds ownership: 53.83% → 56.67% (+2.8%)
2% less capital invested
Capital invested by funds: $1.88B → $1.85B (-$33.9M)
Holders
94
Holding in Top 10
4
Calls
$2.94M
Puts
$2.34M
Top Buyers
| 1 | +$51.7M | |
| 2 | +$51.3M | |
| 3 | +$36.1M | |
| 4 |
BlackRock
New York
|
+$35.2M |
| 5 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
+$26.9M |
Top Sellers
| 1 | -$51.5M | |
| 2 | -$48.2M | |
| 3 | -$24M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.2M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$10.3M |